CSIMarket
 
Ginkgo Bioworks Holdings Inc   (NYSE: DNA)
 

Ginkgo Bioworks Holdings Inc's Customers Performance

DNA



 
DNA's Source of Revenues During the corresponding time, Ginkgo Bioworks Holdings Inc saw a revenue deteriorated by -59.37 % year on year, sequentially revenue grew by 3.5 %. While revenue at the Ginkgo Bioworks Holdings Inc 's corporate clients

List of DNA Customers




for the same period Ginkgo Bioworks Holdings Inc revnue deteriorated by -59.37 % year on year, sequentially revenue grew by 3.5 %.

List of DNA Customers

Ginkgo Bioworks Holdings Inc's Business Units
Reportable    196.62 % of total Revenue






Ginkgo Bioworks Holdings Inc's Comment on Sales, Marketing and Customers



Ginkgo operates in two business segments: cell engineering and biosecurity. In cell engineering, the company offers tools and biological research and development (R&D) services to support the discovery and manufacturing of new products across various industries, including medicine, agriculture, industrial biotechnology, and government. These services assist in developing therapeutics and vaccines, advancing sustainability and food security, improving manufacturing performance and environmental impact, and supporting strategic R&D priorities of the United States and its allies. Ginkgo's offerings aim to enhance success rates, speed, and cost efficiency compared to traditional in-house laboratory work, utilizing its Autonomous Lab and data assets. In the biosecurity segment, Ginkgo provides services focused on identifying, monitoring, preventing, mitigating, and protecting against biological threats.





Ginkgo Bioworks Holdings Inc’s Comment on Sales, Marketing and Customers


Ginkgo operates in two business segments: cell engineering and biosecurity. In cell engineering, the company offers tools and biological research and development (R&D) services to support the discovery and manufacturing of new products across various industries, including medicine, agriculture, industrial biotechnology, and government. These services assist in developing therapeutics and vaccines, advancing sustainability and food security, improving manufacturing performance and environmental impact, and supporting strategic R&D priorities of the United States and its allies. Ginkgo's offerings aim to enhance success rates, speed, and cost efficiency compared to traditional in-house laboratory work, utilizing its Autonomous Lab and data assets. In the biosecurity segment, Ginkgo provides services focused on identifying, monitoring, preventing, mitigating, and protecting against biological threats.








DNA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Ginkgo Bioworks Holdings Inc 431.56 141.31 -304.39 485
SUBTOTAL 0.00 0.00 0.00 -

Sources: Ginkgo Bioworks Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Ginkgo Bioworks Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Ginkgo Bioworks Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.